Duration of untreated psychosis and pathways to care in patients with first-episode psychosis in Iran

Early Intervention in Psychiatry

Volumn 3, Issue 2, 2009, Pages 131-136

  Sharifi, Vandad ^a,b   Kermani Ranjbar, Tahereh ^a   Amini, Homayoun ^a   Alaghband Rad, Javad ^a,c   Salesian, Niloofar ^a   Seddigh, Arshia ^a,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c DALHOUSIE UNIVERSITY   (Canada)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Delivery of health care; Developing countries; Iran; Psychotic disorders

Indexed keywords

ADULT; ARTICLE; CONSULTATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HEALTH CARE DELIVERY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT REFERRAL; PRIORITY JOURNAL; PSYCHOSIS; RURAL AREA; THERAPY DELAY;

ADULT; BIPOLAR DISORDER; DELAYED DIAGNOSIS; FEMALE; HUMANS; IRAN; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 66049142161     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2009.00119.x     Document Type: Article

References (27)

1. Wyatt RJ. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia. Schizophr Res 1991; 5: 201-2.
2. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996; 22: 305-26.
3. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Arch Gen Psychiatry 2005; 62: 975-83.
4. Norman RM, Lewis SW, Marshall M. Duration of untreated psychosis and its relationship to clinical outcome. Br J Psychiatry Suppl 2005; 48: S19-23.
5. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. Am J Psychiatry 2005; 162: 1785-804.
6. Norman RM, Malla AK. Duration of untreated psychosis: A critical examination of the concept and its importance. Psychol Med 2001; 31: 381-400.
7. Singh SP, Grange T. Measuring pathways to care in first-episode psychosis: A systematic review. Schizophr Res 2006; 81: 75-82.
8. Oosthuizen P, Emsley RA, Keyter N, Niehaus DJ, Koen L. Duration of untreated psychosis and outcome in first-episode psychosis. Perspective from a developing country. Acta Psychiatr Scand 2005; 111: 214-19.
9. Padmavathi R, Rajkumar S, Srinivasan TN. Schizophrenic patients who were never treated - a study in an Indian urban community. Psychol Med 1998; 28: 1113-17.
10. Tirupati NS, Rangaswamy T, Raman P. Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years. Aust N Z J Psychiatry 2004; 38: 339-43.
11. Yasamy MT, Shahmohammadi D, Bagheri Yazdi SA et al. Mental health in the Islamic Republic of Iran: Achievements and areas of need. East Mediterr Health J 2001; 7: 381-91.
12. Sadeghi M, Mirsepasi G. Psychiatry in Iran. Int Psychiatry 2005; 10: 10-12.
13. Alaghband-Rad J, Boroumand M, Amini H et al. Non-affective acute remitting psychosis: A preliminary report from Iran. Acta Psychiatr Scand 2006; 113: 101-96.
14. Amini H, Alaghband-Rad J, Omid A et al. Diagnostic stability in patients with first-episode psychosis. Australas Psychiatry 2005; 13: 388-92.
15. Sharifi V, Alaghband-Rad J, Amini H et al. Towards models for aftercare of patients with a first episode of psychosis in Iran as a developing country. Schizophr Res 2006; 86: S164-5.
16. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO. Premorbid functioning versus duration of untreated psychosis in 1year outcome in first-episode psychosis. Schizophr Res 2000; 45: 1-9.
17. Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: Impact on 2-year outcome. Psychol Med 2004; 34: 277-84.
18. Verdoux H, Liraud F, Gonzales B et al. Prognosis of short-term outcome in the first admission for psychosis. Encephale 1999; 25: 213-20.
19. McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of course? Biol Psychiatry 1999; 46: 899-907.
20. Susser E, Wanderling J. Epidemiology of nonaffective acute remitting psychosis vs schizophrenia. Sex and sociocultural setting. Arch Gen Psychiatry 1994; 51: 294-301.
21. Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiatry 2000; 157: 60-6.
22. Lincoln C, Harrigan S, McGorry PD. Understanding the topography of the early psychosis pathways. An opportunity to reduce delays in treatment. Br J Psychiatry Suppl 1998; 172 (33): 21-5.
23. Chong SA, Mythily S, Lum A, Chan YH, McGorry P. Determinants of duration of untreated psychosis and the pathway to care in Singapore. Int J Soc Psychiatry 2005; 51: 55-62.
24. Edwards J, Harris MG, Bapat S. Developing services for first-episode psychosis and the critical period. Br J Psychiatry Suppl 2005; 48: S91-7.
25. Chen EY, Dunn EL, Miao MY et al. The impact of family experience on the duration of untreated psychosis (DUP) in Hong Kong. Soc Psychiatry Psychiatr Epidemiol 2005; 40: 350-6.
26. Morgan C, Abdul-Al R, Lappin JM et al. Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study. Br J Psychiatry 2006; 189: 446-52.
27. Hafner H, Riecher-Rossler A, Hambrecht M et al. IRAOS: An instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 1992; 6: 209-23.